Lung Tumor Resection Ups Melanoma Survival

2007 ◽  
Vol 38 (7) ◽  
pp. 46
Author(s):  
ALICIA AULT
Keyword(s):  
Lung Tumor ◽  
Tumor Resection

scholarly journals Perioperative outcomes of combined heart surgery and lung tumor resection: A systematic review and meta-analysis

2020 ◽  
Author(s):  
Shizhao Cheng ◽  
Yiyao Jiang ◽  
Xin Li ◽  
Xike Lu ◽  
Xun Zhang ◽  
...  
Keyword(s):  
Complication Rate ◽  
Subgroup Analysis ◽  
Heart Surgery ◽  
Lung Tumor ◽  
Meta Analysis ◽  
Tumor Resection ◽  
Perioperative Outcomes ◽  
Off Pump ◽  
Lung Cancer Patients ◽  
Pump Cabg

Abstract Objective: The coexistence of concomitant lesions of the heart and lungs needed surgical intervention is increasing. Simultaneous cardiac surgery with pulmonary resection can solve the lesions at the same time, thus avoiding the second operation. However, concern exists regarding the potentially increased mortality and complication rate of simultaneous surgery and the adequacy of lung exposure during heart surgery. Therefore, we performed a meta-analysis to evaluate the perioperative mortality and complication rate of combined heart surgery and lung tumor resection.Methods: A comprehensive literature search was performed in July 2020. PubMed, Embase and Web of Science databases were searched to collect studies reported the perioperative outcomes of combined heart surgery and lung tumor resection. Two reviewers independently screened literatures, extracted data and assessed the risk of bias of included studies. Pooled proportion and its 95% confidence intervals (95% CI) was performed by R version 3.6.1 using the meta package.Results: A total of 536 patients from 29 studies were included in this analysis. Overall, the results of this meta-analysis showed that the pooled proportion of operative mortality was 0.01 (95% CI: 0.00, 0.03) and the pooled proportion of postoperative complications was 0.40 (95% CI: 0.24, 0.57) for patients underwent combined cardiothoracic surgery. Subgroup analysis by lung pathology revealed that, for lung cancer patients, the pooled proportion of anatomical lung resection was 0.99 (95% CI: 0.95, 1.00), and the pooled proportion of systematic lymph node dissection or sampling was 1.00 (95% CI: 1.00, 1.00). Subgroup analysis by heart surgery procedures found that the pooled proportion of postoperative complications of coronary artery bypass grafting (CABG) patients using off-pump method was 0.17 (95% CI: 0.01, 0.43), while the pooled proportion of on-pump method was 0.61 (95% CI: 0.38, 0.82).Conclusion: This study presented that combined heart surgery and lung tumor resection had a low mortality rate and an acceptable complication rate. Subgroup analysis revealed most lung cancer patients underwent uncompromised anatomical resection and mediastinal lymph node sampling or dissection during combined cardiothoracic surgery, and showed off-pump CABG could potentially reduce the complication rate compared with on-pump CABG. While further researches are still needed.

A nanomaterial-based breath test for short-term follow-up after lung tumor resection

2013 ◽  
Vol 9 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Yoav Y. Broza ◽  
Ran Kremer ◽  
Ulrike Tisch ◽  
Arsen Gevorkyan ◽  
Ala Shiban ◽  
...  
Keyword(s):  
Breath Test ◽  
Lung Tumor ◽  
Tumor Resection ◽  
Short Term

scholarly journals Perioperative outcomes of combined heart surgery and lung tumor resection: a systematic review and meta-analysis

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Shizhao Cheng ◽  
Yiyao Jiang ◽  
Xin Li ◽  
Xike Lu ◽  
Xun Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lymph Node ◽  
Heart Surgery ◽  
Lung Tumor ◽  
Meta Analysis ◽  
Tumor Resection ◽  
Perioperative Outcomes ◽  
Complication Rates ◽  
Off Pump ◽  
Pump Cabg

Abstract Objective The prevalence of patients with concomitant heart and lung lesions requiring surgical intervention is increasing. Simultaneous cardiac surgery and pulmonary resection avoids the need for a second operation. However, there are concerns regarding the potentially increased mortality and complication rates of simultaneous surgery and the adequacy of lung exposure during heart surgery. Therefore, we performed a meta-analysis to evaluate the perioperative mortality and complication rates of combined heart surgery and lung tumor resection. Methods A comprehensive literature search was performed in July 2020. The PubMed, Embase, and Web of Science databases were searched to identify studies that reported the perioperative outcomes of combined heart surgery and lung tumor resection. Two reviewers independently screened the studies, extracted data, and assessed the risk of bias of included studies. Pooled proportions and 95% confidence intervals (95% CI) were calculated by R version 3.6.1 using the meta package. Results A total of 536 patients from 29 studies were included. Overall, the pooled proportion of operative mortality was 0.01 (95% CI: 0.00, 0.03) and the pooled proportion of postoperative complications was 0.40 (95% CI: 0.24, 0.57) for patients who underwent combined cardiothoracic surgery. Subgroup analysis by lung pathology revealed that, for patients with lung cancer, the pooled proportion of anatomical lung resection was 0.99 (95% CI: 0.95, 1.00) and the pooled proportion of systematic lymph node dissection or sampling was 1.00 (95% CI: 1.00, 1.00). Subgroup analysis by heart surgery procedure found that the pooled proportion of postoperative complications of patients who underwent coronary artery bypass grafting (CABG) patients using the off-pump method was 0.17 (95% CI: 0.01, 0.43), while the pooled proportion of complications after CABG using the on-pump method was 0.61 (95% CI: 0.38, 0.82). Conclusion Combined heart surgery and lung tumor resection had a low mortality rate and an acceptable complication rate. Subgroup analyses revealed that most patients with lung cancer underwent uncompromised anatomical resection and mediastinal lymph node sampling or dissection during combined cardiothoracic surgery, and showed off-pump CABG may reduce the complication rate compared with on-pump CABG. Further researches are still needed to verify these findings.

scholarly journals Giant cell arteritis and polymyalgia rheumatica as first manifestation of typical pulmonary carcinoid tumor

Reumatismo ◽  
2016 ◽  
Vol 67 (4) ◽  
pp. 165 ◽  
Author(s):  
T. Aguiar ◽  
M. B. Vincent
Keyword(s):  
Giant Cell Arteritis ◽  
Giant Cell ◽  
Polymyalgia Rheumatica ◽  
Lung Tumor ◽  
Systemic Vasculitis ◽  
Hormone Secretion ◽  
Tumor Resection ◽  
Unknown Origin ◽  
Pulmonary Carcinoid ◽  
Inappropriate Antidiuretic Hormone Secretion

Giant cell arteritis (GCA), a systemic vasculitis of unknown origin, may appear rarely as a paraneoplastic syndrome. Cases secondary to pulmonary neuroendocrine tumors have not been reported. A 75-year-old female developed prednisone-responsive GCA/polymyalgia rheumatica (PMR) shortly followed by syndrome of inappropriate antidiuretic hormone secretion. An 8 mm carcinoid lung tumor with positron emission tomography normal uptake was found. After a thoracoscopic tumor resection the patient experienced complete clinical and laboratory remission. This is the first report of GCA with PMR in the context of carcinoid lung tumor. It emphasizes the role of paraneoplastic vasculitis as a possible cause of GCA.

The visibility of virtual-assisted lung mapping (VAL-MAP) on computed tomography for thoracoscopic lung tumor resection

2016 ◽  
Author(s):  
Hiroshi Nakaoka ◽  
Atsushi Kitamura ◽  
Kohei Okafuji ◽  
Ryosuke Tsugitomi ◽  
Tomoyuki Tanigawa ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Tumor ◽  
Tumor Resection

scholarly journals Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis

BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Zhensheng Li ◽  
Dongxing Shen ◽  
Jian Zhang ◽  
Jun Zhang ◽  
Fang Yang ◽  
...  
Keyword(s):  
Overall Survival ◽  
Brain Metastases ◽  
Lung Tumor ◽  
Tumor Resection ◽  
Prognostic Index ◽  
Whole Brain Radiotherapy ◽  
Progression Free Survival ◽  
Intracranial Tumor ◽  
Tumor Control ◽  
Cox Models

Abstract Background The relationship between whole brain radiotherapy (WBRT) dose with intracranial tumor control and overall survival (OS) in patients with non-small cell lung cancer (NSCLC) brain metastases (BM) is largely unknown. Methods We retrospectively analyzed 595 NSCLC BM patients treated consecutively at the Fourth Hospital of Hebei Medical University between 2013 to 2015. We assigned the patients into 4 dose groups of WBRT: none, < 30, 30–39, and ≥ 40 Gy and assessed their relationship with OS and intracranial progression-free survival (iPFS). Cox models were utilized. Covariates included sex, age, KPS, BM lesions, extracranial metastasis, BM and lung tumor resection, chemotherapy, targeted therapy, and focal radiotherapy modalities. Results Patients had a mean age of 59 years and were 44% female. Their median survival time (MST) of OS and iPFS were 9.3 and 8.9 months. Patients receiving none (344/58%), < 30 (30/5%), 30–39 (93/16%), and ≥ 40 (128/22%) Gy of WBRT had MST of OS (iPFS) of 7.3 (6.8), 6.0 (5.4), 10.3 (11.9) and 11.9 (11.9) months, respectively. Compared to none, other WBRT groups had adjusted HRs for OS - 1.23 (p > 0.20), 0.72 (0.08), 0.61 (< 0.00) and iPFS - 1.63 (0.03), 0.71 (0.06), 0.67 (< 0.01). Compared to 30–39 Gy, WBRT dose ≥40 Gy was not associated with improved OS and iPFS (all p > 0.40). Stratified analyses by 1–3 and ≥ 4 BM lesions and adjustment analyses by each prognostic index of RPA class, Lung-GPA and Lung-molGPA supported these relationships as well. Conclusions Compared to none, WBRT doses ≥30 Gy are invariably associated with improved intracranial tumor control and survival in NSCLC BM patients.

Sign in / Sign up

Export Citation Format

Share Document